Do we need another SGLT2 inhibitor?

E-ISSN： 2047-2900|32|2|47-48a

ISSN： 2047-2897

Source： PRACTICAL DIABETES (INCORPORATING CARDIABETES), Vol.32, Iss.2, 2015-03, pp. : 47-48a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Continuing Cardiology Education. Do we really need another new cardiology journal?

Continuing Cardiology Education, Vol. 1, Iss. 1, 2015-12 ,pp. : 1-1

John Wiley & Sons Inc

Access to resources Recommend Favorite

Do We Need Surgical Oncologists?

Oncology Research and Treatment, Vol. 25, Iss. 4, 2002-09 ,pp. : 306-307

Karger

Access to resources Recommend Favorite

Do We Need Experimental Oncology?

Oncology Research and Treatment, Vol. 25, Iss. 6, 2003-01 ,pp. : 500-500

Karger

Access to resources Recommend Favorite

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo‐Controlled Trial

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 158-169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Do We Need Three Players in COPD Treatment?

Respiration, Vol. 86, Iss. 4, 2013-08 ,pp. : 275-276

Karger

Access to resources Recommend Favorite